Medical Students' Evaluation of Dyslipidemia and LIPoprotein(a) Study

Recruiting

• Conditions: Insight Into the Prevalence of Elevated Lp(a) Among Greek Medical Students

• Registration Number: NCT06482476
• Lead Sponsor: University of Ioannina

Brief Summary

This cross-sectional study aims to determine the prevalence of elevated Lp(a) levels among volunteer medical students at the Faculty of Medicine, University Hospital of Ioannina, Greece. Data collected will include demographic information, family and medical history, as well as lifestyle habits, and the study aims to provide valuable insights into the prevalence of elevated Lp(a) among Greek medical students.

Detailed Description

Lipoprotein(a) \[Lp(a)\] has emerged as a prevalent monogenetic cardiovascular risk factor globally. Despite its significance, clinical attention for elevated Lp(a) is suboptimal. This cross-sectional study aims to determine the prevalence of elevated Lp(a) levels among volunteer medical students at the Faculty of Medicine, University Hospital of Ioannina, Greece, as well as gather data on the demographic characteristics and medical history of this population. Statistical analysis will assess Lp(a) levels, prevalence, and associations with demographic and cardiovascular risk factors. The study aims to provide valuable insights into the prevalence of elevated Lp(a) among Greek medical students, emphasizing the importance of awareness, early diagnosis, and management of this cardiovascular risk factor.

Study Timeline

• Status Verified: 2024-06
• Study Start: 2024-06
• Study First Submitted: 2024-06-25
• Study First Submitted QC: 2024-06-25
• Last Update Submitted: 2024-06-25
• Primary Completion: 2024-07
• Study First Posted: 2024-07-01
• Last Update Posted: 2024-07-01
• Study Completion: 2024-10

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 246

Inclusion Criteria

• Medical students at the Faculty of Medicine, University Hospital of Ioannina, Greece.

Exclusion Criteria

• Inability/unwillingness to give informed consent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Lp(a) elevated	At time of measurement
Lp(a) beneath cut-off	At time of measurement

Trial Locations

Locations (1)

University Hospital of Ioannina; 🇬🇷 Ioánnina, Ioannina, Greece